| Date Filed | Type | Description |
| 09/29/2023 |
4
| Williams Donald Allen (Director) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Bought 20,000 shares
@ $0.54, valued at
$10.8k
|
|
| 08/02/2023 |
4
| Williams Donald Allen (Director) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Granted 59,405 shares
@ $1.01, valued at
$60k
|
|
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2022 |
4
| Williams Donald Allen (Director) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Granted 48,340 options to buy
@ $2.32, valued at
$112.1k
|
|
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/19/2020 |
4
| Williams Donald Allen (Director) has filed a Form 4 on Alphatec Holdings, Inc.|
Txns:
| Granted 26,956 shares
@ $0 |
|
| 06/19/2020 |
4/A
| Williams Donald Allen (Director) has filed a Form 4 on Alphatec Holdings, Inc. |
| 06/17/2020 |
4
| Williams Donald Allen (Director) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Granted 30,000 options to buy
@ $18.9, valued at
$567k
|
|
| 06/17/2020 |
3
| Williams Donald Allen (Director) has filed a Form 3 on Forte Biosciences, Inc. |
| 06/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/13/2019 |
4
| Williams Donald Allen (Director) has filed a Form 4 on Alphatec Holdings, Inc.|
Txns:
| Bought 4,000 shares
@ $2.4725, valued at
$9.9k
|
|
| 08/01/2018 |
4
| Williams Donald Allen (Director) has filed a Form 4 on Alphatec Holdings, Inc.|
Txns:
| Granted 20,492 shares
@ $0 |
|
| 04/18/2018 |
4
| Williams Donald Allen (Director) has filed a Form 4 on Marina Biotech, Inc.|
Txns:
| Granted 18 convertible preferred
@ $0.5, valued at
$9
Granted 135,000 options to buy
@ $0.55, valued at
$74.3k
|
|
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/16/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/17/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/30/2016 |
4
| Williams Donald Allen (Director) has filed a Form 4 on Akari Therapeutics Plc|
Txns:
| Granted 1,300,000 options to buy
@ $0.1454, valued at
$189k
|
|
| 06/30/2016 |
3
| Williams Donald Allen (Director) has filed a Form 3 on Akari Therapeutics Plc |